샘플 요청 목록

 카트 문의
시장보고서
상품코드
1785892

브루셀라병 백신 시장

Brucellosis Vaccines
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 276 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 브루셀라병 백신 시장은 2030년까지 3억 600만 달러에 달할 전망

2024년에 2억 4,930만 달러로 추정되는 세계의 브루셀라병 백신 시장은 2024-2030년의 분석 기간에 CAGR 3.5%로 성장하며, 2030년에는 3억 600만 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 RB51 백신은 CAGR 4.0%를 기록하며, 분석 기간 종료시에는 1억 6,200만 달러에 달할 것으로 예측됩니다. S19 백신 분야의 성장률은 분석 기간 중 CAGR 3.3%로 추정됩니다.

미국 시장은 6,790만 달러로 추정, 중국은 CAGR 6.6%로 성장 예측

미국의 브루셀라병 백신 시장은 2024년에는 6,790만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 6,130만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 6.6%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.3%와 2.7%로 예측됩니다. 유럽에서는 독일이 CAGR 2.0%로 성장할 것으로 예측됩니다.

세계의 브루셀라병 백신 시장 - 주요 동향과 촉진요인 정리

브루셀라병 백신이란 무엇이며, 왜 수의학 및 인체 건강에 중요한가?

브루셀라병 백신은 가축과 경우에 따라서는 사람에게도 영향을 미치는 브루셀라병 감염을 예방하는 데 매우 중요합니다. 브루셀라균에 의해 발생하는 브루셀라병은 전염성이 매우 강한 인수공통전염병으로 가축의 번식장애, 발열, 관절통, 피로감 등 심각한 건강 합병증을 유발합니다. 이 질병은 소, 양, 염소, 염소, 돼지에서 가장 많이 발생하며, 직접 접촉, 오염된 사료, 살균되지 않은 유제품을 통해 감염됩니다. 백신 접종은 여전히 가장 효과적인 예방 수단으로 축산업의 경제적 손실을 줄이고 인체 감염 위험을 최소화할 수 있습니다. 가장 일반적으로 사용되는 백신으로는 S19, RB51(소용), Rev-1(양 및 염소용) 등이 있으며, 모두 대규모 브루셀라병의 확산을 억제하는 데 도움이 되고 있습니다. 최근 유전자 재조합 백신, DNA 백신, 벡터 기반 백신의 발전으로 면역원성, 안전성, 예방 효과가 더욱 향상되고 있습니다.

브루셀라병 백신의 판도를 바꿀 신기술은?

생명공학과 면역학의 발전에 따라 브루셀라병 백신의 개발은 눈에 띄게 발전하고 있습니다. S19나 RB51과 같은 기존의 약독화 생백신은 효과적이긴 하지만 병원성이 남아있을 위험이 있고, 생물학적 안전성 문제로 인해 접종이 제한되는 경우도 있습니다. 현대의 백신 전략은 병원성 위험을 줄이면서 면역원성을 유지하는 유전자변형 백신에 초점을 맞추었습니다. 또한 살아있는 박테리아를 도입하지 않고 특정 박테리아 항원을 이용하여 면역을 유도하는 아단위 백신의 기술 혁신도 연구를 통해 추진되고 있습니다. 또한 나노 보조제 및 리포좀 전달 시스템은 백신의 효능과 안정성을 높이고 가축의 면역반응을 개선하고 있습니다. 인간, 동물, 환경의 건강 전략을 통합하는 원헬스 개념의 부상으로 전염병이 유행하는 지역에서 감시를 강화하고 백신을 채택하게 되었습니다. 세계동물보건기구(WOAH), 유엔식량농업기구(FAO) 등의 정부 및 기관은 이 질병을 전 세계에서 근절하기 위해 집단 백신 접종 프로그램 실시, 혈청학적 모니터링, 수의학 인프라 개선에 힘쓰고 있습니다.

브루셀라병 백신 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다.

주요 성장 촉진요인으로는 가축 사육두수 증가, 인수공통전염병에 대한 인식 증가, 질병 관리에 대한 정부의 엄격한 규제 등을 꼽을 수 있습니다. 동물용 생물제제에 대한 투자 증가와 새로운 백신 제제의 연구개발이 시장 확대에 더욱 박차를 가하고 있습니다. 안전한 축산물에 대한 전 세계적인 수요와 낙농 안전 규제가 백신 채택 증가를 가져오고 있습니다. 또한 기후 변화와 세계 무역의 확대는 브루셀라증 확산에 영향을 미치고 있으며, 각국은 예방 백신 접종 전략의 실행을 촉구하고 있습니다. 동물병원, 진단 실험실, 가축 관리 프로그램의 확대도 시장을 강화하고 있습니다. 아시아태평양과 아프리카 등 브루셀라병이 여전히 유행하고 있는 지역에서는 정부 지원 백신 접종 구상이 첨단 백신에 대한 수요를 가속화하고 있으며, 업계는 크게 성장할 준비가 되어 있습니다.

부문

유형(RB51 백신, S19 백신, B19 백신, 기타 유형); 용도(소용, 양용, 산양용)

조사 대상 기업의 예

  • Anicon Labor GmbH
  • Biogenesis Bago
  • Bioveta a.s.
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Colorado Serum Company
  • CZ Vaccines
  • Fivet Animal Health
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Jordan Bio-Industries Center(JOVAC)
  • Laboratorios Tornel
  • Merck & Co., Inc.
  • MSD Animal Health
  • Phibro Animal Health Corporation
  • Vaxxinova
  • VETAL Animal Health Products Inc.
  • Veterinary Technologies Corporation
  • Virbac
  • Zoetis Inc.

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴에 의해 시장과 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.13

Global Brucellosis Vaccines Market to Reach US$306.0 Million by 2030

The global market for Brucellosis Vaccines estimated at US$249.3 Million in the year 2024, is expected to reach US$306.0 Million by 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. RB51 Vaccine, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$162.0 Million by the end of the analysis period. Growth in the S19 Vaccine segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$67.9 Million While China is Forecast to Grow at 6.6% CAGR

The Brucellosis Vaccines market in the U.S. is estimated at US$67.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$61.3 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Brucellosis Vaccines Market - Key Trends & Drivers Summarized

What Are Brucellosis Vaccines and Why Are They Critical in Veterinary and Human Health?

Brucellosis vaccines are crucial in preventing Brucella infections, which affect livestock and, in some cases, humans. Brucellosis, caused by Brucella bacteria, is a highly contagious zoonotic disease that leads to reproductive failures in animals and severe health complications in humans, including fever, joint pain, and fatigue. The disease is most prevalent in cattle, sheep, goats, and pigs, with transmission occurring through direct contact, contaminated feed, or unpasteurized dairy products. Vaccination remains the most effective preventive measure, reducing economic losses in the livestock industry and minimizing the risk of human infection. The most commonly used vaccines include S19, RB51 (for cattle), and Rev-1 (for sheep and goats), all of which help in controlling the spread of brucellosis at a large scale. Recent advancements in recombinant vaccines, DNA vaccines, and vector-based vaccines have further enhanced immunogenicity, safety, and longevity of protection.

How Are Emerging Technologies Transforming the Brucellosis Vaccine Landscape?

With advancements in biotechnology and immunology, brucellosis vaccine development has evolved significantly. Traditional live-attenuated vaccines like S19 and RB51, though effective, carry risks of residual virulence and are restricted in certain cases due to biosafety concerns. Modern vaccine strategies now focus on genetically modified vaccines that retain immunogenicity while reducing risks of pathogenicity. Research is also driving innovation in subunit vaccines, which use specific bacterial antigens to trigger immunity without introducing live bacteria. Furthermore, nano-adjuvants and liposomal delivery systems are enhancing vaccine efficacy and stability, improving immune response in livestock. The rise of One Health initiatives-which integrate human, animal, and environmental health strategies-has led to increased surveillance and adoption of vaccines in endemic regions. Governments and organizations such as the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) are working to implement mass vaccination programs, serological monitoring, and improved veterinary infrastructure to eradicate the disease globally.

The Growth in the Brucellosis Vaccines Market Is Driven by Several Factors…

Key growth drivers include rising livestock population, increasing awareness about zoonotic diseases, and stringent government regulations on disease control. Growing investments in veterinary biologics and R&D for novel vaccine formulations have further fueled market expansion. The global demand for safe livestock products and dairy safety regulations has led to an uptick in vaccine adoption. Additionally, climate change and global trade expansion are influencing the spread of brucellosis, prompting nations to implement preventive vaccination strategies. The expansion of veterinary clinics, diagnostic laboratories, and livestock management programs is also bolstering the market. In regions such as Asia-Pacific and Africa, where brucellosis remains endemic, government-backed vaccination initiatives are accelerating the demand for advanced vaccines, making the industry poised for significant growth.

SCOPE OF STUDY:

The report analyzes the Brucellosis Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (RB51 Vaccine, S19 Vaccine, B19 Vaccine, Other Types); Application (Cattle Application, Sheep Application, Goat Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Anicon Labor GmbH
  • Biogenesis Bago
  • Bioveta a.s.
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Colorado Serum Company
  • CZ Vaccines
  • Fivet Animal Health
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Jordan Bio-Industries Center (JOVAC)
  • Laboratorios Tornel
  • Merck & Co., Inc.
  • MSD Animal Health
  • Phibro Animal Health Corporation
  • Vaxxinova
  • VETAL Animal Health Products Inc.
  • Veterinary Technologies Corporation
  • Virbac
  • Zoetis Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Brucellosis Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Brucellosis in Livestock Drives Global Demand for Effective Vaccination Programs
    • Government-Led Eradication Campaigns and Mandatory Vaccination Policies Propel Market Growth
    • Increased Zoonotic Transmission Risk of Brucellosis to Humans Strengthens Public Health Focus on Animal Vaccines
    • Expansion of Commercial Dairy and Livestock Farming Fuels Adoption of Preventive Veterinary Vaccines
    • Technological Advancements in Live Attenuated and Inactivated Vaccine Development Enhance Efficacy and Safety
    • Growing Research into Novel Subunit and DNA-Based Brucellosis Vaccines Expands Future Market Potential
    • Strategic Support from Global Animal Health Organizations (OIE, FAO, WHO) Encourages Vaccination Initiatives
    • Increasing Public and Private Investment in Animal Health Infrastructure Strengthens Distribution and Access
    • Expansion of Brucellosis Surveillance Programs Enhances Disease Detection and Vaccine Coverage
    • Rising Demand for Multi-Valent and Cross-Protective Vaccines Boosts Innovation in Combination Vaccine Solutions
    • Challenges in Cold Chain Management and Vaccine Delivery in Remote Areas Drive Interest in Thermo-Stable Vaccines
    • High Economic Losses from Brucellosis Outbreaks in Livestock Drive ROI-Backed Adoption of Vaccination Programs
    • Regulatory Approvals and Harmonization of Animal Vaccine Guidelines Influence Product Commercialization
    • Emerging Research on Human Brucellosis Vaccines Opens Long-Term Opportunities in Zoonotic Disease Control
    • Regional Livestock Population Growth, Particularly in Asia-Pacific and Africa, Expands Market for Preventive Vaccines
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Brucellosis Vaccines Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Brucellosis Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Brucellosis Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Brucellosis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for RB51 Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for RB51 Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for RB51 Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for S19 Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for S19 Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for S19 Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for B19 Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for B19 Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for B19 Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cattle Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cattle Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cattle Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Sheep Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Sheep Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Sheep Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Goat Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Goat Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Goat Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • JAPAN
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • CHINA
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • EUROPE
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Brucellosis Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Brucellosis Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Brucellosis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • FRANCE
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • GERMANY
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Brucellosis Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Brucellosis Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Brucellosis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • INDIA
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Brucellosis Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Brucellosis Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Brucellosis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Brucellosis Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Brucellosis Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Brucellosis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • AFRICA
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제